Department of Population Health Sciences, University of Utah Health, Salt Lake City, Utah, USA
Department of Psychiatry and Behavioral Sciences, Northwestern University, Evanston, Illinois, USA.
BMJ Open. 2023 Mar 16;13(3):e070216. doi: 10.1136/bmjopen-2022-070216.
Despite decreased rates of new infections, HIV/AIDS continues to impact certain US populations. In order to achieve the goals laid out in the Ending the HIV Epidemic (EHE) in the US initiative, implementation science is needed to expand the sustained use of effective prevention and treatment interventions, particularly among priority populations at risk for and living with HIV/AIDS. Over 200 HIV-related implementation studies have been funded by the US National Institutes of Health. Therefore, a comprehensive review of the literature identifying implementation determinants (barriers and facilitators) and categorising implementation strategies across the continuum of HIV prevention and care in the USA is appropriate and needed to enhance current knowledge and help achieve the goals laid out in the EHE national strategic plan.
This systematic review protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Between November 2020 and January 2022, a broad database search strategy of Ovid MEDLINE, PsycINFO and Web of Science was conducted to capture implementation-related studies along the HIV prevention and care continuum. Articles were eligible for inclusion if they were: conducted in the USA, published after the year 2000, written in English, related to HIV/AIDS, focused on outcomes related to dissemination and implementation (ie, did not test/evaluate/explore implementation determinants or strategies) and were behavioural studies (ie, not basic science). We plan to conduct three systematic reviews to identify and categorise determinants and strategies associated with three HIV focus areas: pre-exposure prophylaxis, testing/diagnosing and linkage to care, and treatment. Determinants will be coded according to an adapted Consolidated Framework for Implementation Research 2.0. Implementation strategies and outcomes will be categorised in accordance with existing taxonomies and frameworks.
Ethics approval is not applicable. No original data will be collected. Results will be disseminated through peer-reviewed publications, conference presentations and via online tools.
CRD42021233089.
尽管新感染率有所下降,但艾滋病毒/艾滋病仍在影响美国的某些人群。为了实现美国终结艾滋病毒流行倡议中提出的目标,需要实施科学来扩大有效预防和治疗干预措施的持续使用,特别是在感染艾滋病毒/艾滋病风险较高和已经感染艾滋病毒/艾滋病的优先人群中。美国国立卫生研究院已经资助了 200 多项与艾滋病毒相关的实施研究。因此,对文献进行全面审查,确定实施的决定因素(障碍和促进因素),并对美国艾滋病毒预防和护理连续体中的实施策略进行分类,这是恰当和必要的,有助于增进现有知识,并帮助实现终结艾滋病毒流行国家战略计划中提出的目标。
本系统评价方案遵循系统评价和荟萃分析的首选报告项目的指南。在 2020 年 11 月至 2022 年 1 月期间,对 Ovid MEDLINE、PsycINFO 和 Web of Science 进行了广泛的数据库检索策略,以捕获与艾滋病毒预防和护理连续体相关的实施研究。如果文章符合以下条件,就有资格被纳入:在美国进行、发表于 2000 年以后、用英文撰写、与艾滋病毒/艾滋病相关、侧重于与传播和实施相关的结果(即,不测试/评估/探索实施决定因素或策略),以及是行为研究(即,不是基础科学)。我们计划进行三次系统评价,以确定和分类与三个艾滋病毒重点领域相关的决定因素和策略:暴露前预防、检测/诊断和与护理的联系,以及治疗。决定因素将根据改编的实施研究综合框架 2.0 进行编码。实施策略和结果将按照现有分类法和框架进行分类。
不需要伦理批准。不会收集原始数据。结果将通过同行评议的出版物、会议演讲和在线工具进行传播。
PROSPERO 注册号:CRD42021233089。